However, women diagnosed with breast cancer have an elevated risk of a secondary tumor [86], and it seems reasonable to test all TNBC and HGSOC for tissue methylation and offer WBC BRCA1 methylation testing to women diagnosed with a BRCA1 methylated TNBC or HGSOC tumor. Here, BRCA1 is linked to breast carcinoma.